Clinical Trials on Coagulation Protein Disorders in Spain

Total 5988 results

Hospital Universitario La Fe

Unknown

Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients

Hemophilia A | Factor VIII

Spain
Universidad Católica San Antonio de Murcia

Unknown

Validation of Questionnaires HAL and HEP (VALIDATION)

Haemophilia

Spain
University of Valencia
Shire

Completed

A Progressive Resistance Training Program in Patients With Haemophilia

Haemophilia

Spain
ANA TORRES-ORTUÑO
Pfizer

Unknown

Adherence to Treatment in Hemophilia (ADHERENCE)

Haemophilia

Spain
Real Fundación Victoria Eugenia
Medtep Inc.

Unknown

Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia

Haemophilia

Spain
Universidad Católica San Antonio de Murcia

Unknown

Assessment of Proprioceptive and Functional Characteristics in Patients With Hemophilia (HE-BALANCE)

Hemophilia

Spain
Universidad de Murcia

Unknown

Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia. (ADHAESIONE)

Haemophilia

Spain
Hospital Universitario La Paz

Unknown

Case-control Pilot Study of the Immune Modulating Effect of FEIBA on Patients With Haemophilia A and Inhibitors

Severe Haemophilia A With Inhibitors

Spain
University of Valencia

Recruiting

Resistance Training With Blood Flow Restriction in Hemophilia (HemoBFR)

Hemophilia

Spain
University of Seville

Terminated

Therapeutic Exercise in Patients With Hemophilia (Hemofisio)

Hemophilia

Spain
University of Valencia
Baxter Healthcare Corporation

Completed

Exploratory Pilot Study of Physical Activity Monitoring in Adult Patients With Haemophilia A by Means of Accelerometry

Hemophilia A, Congenital

Spain
Universidad de Murcia

Completed

Multidisciplinary Evaluation of Patients With Hemophilia (HOLISTIC)

Haemophilia

Spain
Investigación en Hemofilia y Fisioterapia

Recruiting

Extended Half-Life (EHL) Clotting Factor for Improving the Musculoskeletal Health of Patients With Hemophilia

Haemophilia

Spain
Universidad Católica San Antonio de Murcia

Completed

Bilateral Deficit Phenomenon in Patients With Haemophilic Arthropathy (PROPRIO-HE)

Hemophilia

Spain
Spanish Society of Thrombosis and Haemostasis
Francisco Vidal Pérez; Maria Fernanda López Fernández; Almudena Pérez Rodríguez; Irene Corrales Insa and other collaborators

Unknown

Molecular and Clinical Profile of Von Willebrand Disease in Spain (PCM-EVW-ES)

Von Willebrand Disease

Spain
Universidad Católica San Antonio de Murcia

Unknown

Transcultural Multidisciplinary Evaluation of Patients With Hemophili (ibHEro)

Patients With Haemophilia

Spain
Universidad Católica San Antonio de Murcia

Completed

Manual Therapy in Haemophilic Arthropathy of the Knee (ARTHROPA)

Patients With Haemophilia

Spain
Investigación en Hemofilia y Fisioterapia

Not yet recruiting

Conditioned Pain Modulation in Patients With Hemophilia

Hemophilia

Spain
Universidad Católica San Antonio de Murcia

Completed

Physiotherapy in the Haemophilic Arthropathy of the Elbow. (ELBOW)

Patients With Hemophilia

Spain
Novo Nordisk A/S

Completed

Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B

Congenital Bleeding Disorder | Haemophilia A | Haemophilia B

Spain
Investigación en Hemofilia y Fisioterapia

Not yet recruiting

Changes in Intra-articular Parameters by Doppler Ultrasound in Patients With Hemophilic Ankle Arthropathy

Hemophilia

Spain
Investigación en Hemofilia y Fisioterapia

Recruiting

Blood Flow Restriction in Improving Muscle Strength of Patients With Hemophilic Ankle Arthropathy

Hemophilia

Spain
Bayer

Completed

Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery (NO PEACKS)

Hemophilia A

Germany, Spain, Austria, Italy, Slovenia, Greece, Netherlands
Novo Nordisk A/S

Completed

Project to Update the Study of Congenital Haemophilia in Spain (PUCHS)

Congenital Bleeding Disorder | Haemophilia A | Haemophilia B

Spain
Universidad Católica San Antonio de Murcia

Unknown

Myofascial Therapy in Patients With Hemophilic Arthropathy (He-Fascial)

Hemophilia

Spain
Bayer

Active, not recruiting

Study to Learn More About the Safety of Drug Jivi Over a Long Period of Time in Previously Treated Patients With Hemophilia A (Bleeding Disorder Resulting From a Lack of FVIII) Who Are Receiving Jivi Regularly at Their Treating Doctors to Prevent Bleeding (HA-SAFE)

Hemophilia A

Spain, Germany, Austria, Greece, Italy, Slovenia
Baxalta now part of Shire

Terminated

A Phase 1/2 Study of SHP648, an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia B Subjects

Hemophilia B

Turkey, Spain
Instituto de Investigacion Sanitaria La Fe
Pfizer

Completed

Psychology and Physiotherapy Approach of Chronic Pain in Patients With Hemophilia

Haemophilia

Spain
Grifols Therapeutics LLC
Instituto Grifols, S.A.

Recruiting

Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease

Von Willebrand Disease

Spain
Bayer

Completed

International PMS Study - KOGENATE Bayer

Hemophilia A

Switzerland, France, Spain, Sweden, Austria, Italy, Belgium, Denmark, Greece, Netherlands
Patricia Duque González

Completed

Impact of Acquired FXIII Deficiency on Morbidity and Mortality

Acquired Factor XIII Deficiency Disease

Spain
Real Fundación Victoria Eugenia

Completed

Fascial Therapy in Elbow Hemophilic Arthropathy (HeL-Fascial)

Hemophilia

Spain
Investigación en Hemofilia y Fisioterapia

Active, not recruiting

Pain and Joint Status With Psychosocial Factors in Patients With Hemophilia

Hemophilia Arthropathy

Spain
Octapharma

Recruiting

Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study (NuPOWER)

Severe Hemophilia A

Spain, Croatia, Italy, North Macedonia, Serbia
Novo Nordisk A/S

Completed

A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B

Spain
Bayer

Active, not recruiting

Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study) (LIFE-ACTIVE)

Hemophilia A

Canada, Spain, United States, Belgium, Italy, Taiwan, Slovenia
CSL Behring

Completed

A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency

Factor XIII Deficiency

United States, Spain
Novo Nordisk A/S

Completed

Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients

Congenital Bleeding Disorder | Haemophilia A | Haemophilia B

Spain, Germany, Japan
Novo Nordisk A/S

Completed

Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A

Congenital Bleeding Disorder | Haemophilia A

Spain, Germany, Malaysia, Latvia
Novo Nordisk A/S

Terminated

A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC 0172-2021 Administered Subcutaneously to Healthy Male Subjects and Haemophilia Subjects (explorer™2)

Healthy | Congenital Bleeding Disorder | Haemophilia A

Austria, Spain, United Kingdom, France, Germany
Bio Products Laboratory

Terminated

Safety & Efficacy of BPL's High Purity FACTOR X in Treatment of Factor X Deficient Subjects Undergoing Surgery (Ten03)

Factor X Deficiency

United Kingdom, United States, Spain, Turkey
Novo Nordisk A/S

Completed

Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects

Congenital Bleeding Disorder | Haemophilia A

Spain, Germany, Switzerland, Italy, Israel
Octapharma

Not yet recruiting

Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery

Hemophilia A

Spain, France, Finland, Germany, Italy, Serbia
Hoffmann-La Roche

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

Hemophilia A

Spain, Canada, United States, New Zealand, Italy, Poland
Pfizer

Completed

Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting

Hemophilia A

Spain, France, Turkey, Netherlands, Germany, Italy, Ukraine
Bayer

Completed

Study to Gain More Information on How Safe and Effective Jivi Works in Patients With Severe Hemophilia A (Post-marketing Investigation)

Hemophilia A

Bulgaria, Spain, Italy, Poland, Greece, Norway, Denmark
Bayer

Completed

Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment (ECHO)

Hemophilia A

United States, Japan, United Kingdom, Spain
Bio Products Laboratory

Completed

A Study Investigating Treatment Factor X in People With Factor X Deficiency

Factor X Deficiency

United States, Turkey, Germany, Spain, United Kingdom
Laboratoire français de Fractionnement et de Biotechnologies
LFB USA, Inc.

Completed

LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive Procedures (PerSept3)

Hemophilia

United States, Ukraine, Mexico, Russian Federation, South Africa, Spain
Vall d'Hebron Institute of Oncology
European Organisation for Research and Treatment of Cancer - EORTC

Terminated

Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer

Chemotherapy | ColoRectal Cancer | MSI | Resistance, APC

Belgium, Netherlands, Spain, Italy

3

Subscribe